Multiplikator forward rega marang pendapatan Ensysce Biosciences Inc. (ENSC)

Logo grafis Ensysce (ENSC)

Ensysce Biosciences (ENSC) is mitigating ESG risks through the development of abuse-deterrent medications and bioethical compliance. The company's expected P/S ratio demonstrates a fundamental trend where the value of 1.70 aligns with the current metric. High scalability potential is driven by global revenue from proprietary formulas. A unique gastrointestinal drug activation mechanism effectively protects the business from competitors' pricing pressure.

ENSC Ensysce Biosciences, Inc.: Rasio kapitalisasi marang dodolan sing dikarepake ing interval 18.06.2023 - 13.11.2026

ENSC (ensysce.com): rincian analitis lan laporan miturut indikator

- rega pasar lan target rega analis:
Bagan rega Ensysce Biosciences, Inc.|ENSC - Target median analis
- rincian kapitalisasi pasar:
Biji pasar Ensysce Biosciences, Inc.|ENSC - Total Nilai Perusahaan
- rincian valuasi buku bisnis:
Aset Bersih saben Siji Saham Ensysce Biosciences|ENSC - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku ensysce.com|ENSC - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Ensysce Biosciences|ENSC - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Ensysce Biosciences, Inc.|ENSC - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Ensysce Biosciences, Inc.|ENSC - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Ensysce Biosciences|Likuiditas cepet ensysce.com
- data bathi bisnis lan rasio investasi:
ENSC - Penghasilan resik perusahaan|Bathi sing dikarepake Ensysce Biosciences|ENSC - Periode bali modal bisnis|Pangali Forward P/E Ensysce Biosciences, Inc.|ENSC - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Ensysce Biosciences, Inc.|ENSC - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Ensysce Biosciences|ENSC - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ensysce.com|ENSC - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Ensysce Biosciences
- indikator volume dodolan lan pendapatan:
ENSC - Dodolan perusahaan|Prakiraan volume dodolan Ensysce Biosciences, Inc.|ENSC - Rega marang dodolan|Rasio rega marang prakiraan pendapatan Ensysce Biosciences, Inc.
Ringkesan analisis perusahaan:Ensysce ENSC
Sampel barang Ensysce Biosciences Inc.

To assess the value of the innovative TAAP and MPAR platforms from Ensysce Biosciences (ENSC), utilize the expected P/S dynamics, which currently stands at 1.70. This indicator compares market capitalization with projected annual revenue, allowing investors to evaluate the sensitivity of share prices to potential cash gaps and the company's debt load prior to the publication of official financial statements.

Karo sapa Ensysce Biosciences saingan

Rasio rega marang prakiraan pendapatan Indivior INDV|Rasio kapitalisasi marang dodolan sing dikarepake Collegium Pharma (COLL)|CRON: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Canopy Growth Corp.|High Tide Inc. (HITI) - Rasio rega marang prakiraan pendapatan|ACB - Rasio kapitalisasi marang dodolan sing dikarepake|ACHV (Achieve Life Sciences, Inc.) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Skye Bioscience Inc. (SKYE)|Multiplikator Forward P/S ANEB|INCR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Nutriband - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan NSRX|IGC Pharma Inc - Multiplikator Forward P/S|MIRA: Rasio rega marang prakiraan pendapatan|FLGC: Multiplikator Forward P/S|IMCC - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Adial Pharmaceuticals Inc.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Artelo ARTL|Rasio rega marang prakiraan pendapatan Titan Pharmaceuticals (TTNP)|Rasio kapitalisasi marang dodolan sing dikarepake Greenlane Holdings, Inc.|Multiplikator Forward P/S INM (InMed Pharma)|AKAN - Multiplikator forward rega marang pendapatan|Enveric Biosciences - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Bright Green BGXX|HPCO: Multiplikator Forward P/S